Delayed Nyse 04:01:42 2023-09-22 pm EDT |
|
5-day change | 1st Jan Change | |
285.28 USD | +0.29% | -2.56% | +16.68% |
Business Summary
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Number of employees : 51,000
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
MedSurg and Neurotechnology
57.5
%
| 9,538 | 55.8 % | 10,611 | 57.5 % | +11.25% |
Orthopaedics and Spine
42.5
%
| 7,570 | 44.2 % | 7,838 | 42.5 % | +3.54% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
73.9
%
| 12,321 | 72.0 % | 13,638 | 73.9 % | +10.69% |
Europe, Middle East, Africa
12.7
%
| 2,299 | 13.4 % | 2,348 | 12.7 % | +2.13% |
Asia Pacific
10.2
%
| 1,973 | 11.5 % | 1,885 | 10.2 % | -4.46% |
Other Countries
3.1
%
| 515 | 3.0 % | 578 | 3.1 % | +12.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Lobo
CEO | Chief Executive Officer | 57 | 2012 |
John Brown
BRD | Director/Board Member | 88 | 2010 |
Glenn Boehnlein
DFI | Director of Finance/CFO | 61 | 2016 |
Dana McMahon
CMP | Compliance Officer | - | 2020 |
Viju Menon
COO | Chief Operating Officer | 55 | 2018 |
Alan Douville
CTO | Chief Tech/Sci/R&D Officer | - | 2018 |
Jason Beach
IRC | Investor Relations Contact | - | 2022 |
Preston Wells
PRN | Corporate Officer/Principal | - | 2022 |
Yin C. Becker
SAM | Sales & Marketing | 59 | 2015 |
William Berry
AUD | Comptroller/Controller/Auditor | 57 | 2011 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brown
BRD | Director/Board Member | 88 | 2010 |
Ronda Stryker
BRD | Director/Board Member | 68 | 1983 |
Kevin Lobo
CHM | Chairman | 57 | 2014 |
Giovanni Caforio
BRD | Director/Board Member | 58 | 2020 |
Director/Board Member | 69 | 2009 | |
Rajeev Suri
BRD | Director/Board Member | 55 | 2017 |
Howard Cox
BRD | Director/Board Member | 79 | 1973 |
Allan C. Golston
BRD | Director/Board Member | 56 | 2011 |
Mary K. Brainerd
BRD | Director/Board Member | 69 | 2017 |
Sherilyn McCoy
BRD | Director/Board Member | 64 | 2018 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 379,778,279 | 355,204,711 ( 93.53 %) | 0 | 93.53 % |
Company contact information

Group companies
Name | Category and Sector | Since |
---|---|---|
Stryker India Pvt Ltd.
|
Health Technology - Medical Specialties
| 1999 |
Stryker-Polska Sp zoo
|
-
| 2018 |
Stryker France SAS
|
Health Technology - Medical Specialties
| 2021 |
Howmedica International S De Rl
|
-
| 2021 |
Stryker EMEA Supply Chain Services BV
|
Health Technology - Medical Specialties
| 2018 |
Stryker International Acquisitions BV
|
Health Technology - Medical Specialties
| 2021 |
Stryker IFSC DAC
|
-
| 2017 |
Stryker Holdings BV
|
-
| 2021 |
Stryker European Operations BV
|
Distribution Services - Medical Distributors
| 2018 |
Sector
Sales per Business
Sales per region
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
284.45USD
Average target price
315.77USD
Spread / Average Target
+11.01%
EPS Revisions
1st Jan change | Capi. (M$) | |
---|---|---|
+16.68% | 108 B $ | |
-31.85% | 11 677 M $ | |
-6.40% | 11 137 M $ | |
-26.55% | 5 609 M $ | |
+72.34% | 3 659 M $ | |
-3.49% | 2 830 M $ | |
-12.20% | 2 797 M $ | |
+4.42% | 2 492 M $ | |
-45.54% | 1 952 M $ | |
-5.88% | 1 837 M $ |